openPR Logo
Press release

Counterfeit Drug Detection Devices Market Revenue and Value Chain Till 2020

01-20-2017 03:51 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: SA-BRC

Counterfeit Drug Detection Devices Market Revenue and Value

The United States is supplied with regulated healthcare devices and pharmaceutical ingredients by over 300,000 foreign facilities from across 150 countries as estimated by the USFDA. World Health Organization calculations suggest over 1% of all drugs in developed nations are counterfeit representing a drug market that may be worth billions and lead to countless loss of lives. US-based Centre for Medicines in the public interest estimated that counterfeit drug sales were worth an estimate above US$ 75 billion globally in 2014. WHO estimates also show that over 10% drugs are counterfeit in developing countries with up to 30% fake drugs in extreme cases registered in some developing countries. Counterfeit anti-malaria drugs are one of the largest markets being operated world-wide and the FDA in 2013 has introduced a detection device for combating this challenge. Several drugs may be counterfeit or may contain ineffective amounts of API. The risk of consuming these drugs is untold. Not only would people consume other harmful substances, doctors may increase dosages, harming body further. A weak dose of anti-viral or anti-bacterial medication may increase drug resistance exponentially. Incorrect medication dose may result in renal failure, blood poisoning and liver damage among other serious conditions and even death. Asia-Pacific accounts for the largest share of counterfeit trade happening across the world.

Two of the popular devices currently being employed by authorities are the CD-3 introduced by FDA and PharmaCheck by Zaman. The working principles for both are different as the FDA device provides ultraviolet to infrared light on an object to detect and match the original drug product. The CD3 emits 10 different wavelengths of light between ultraviolet and infrared imaging which is used on tablets and capsules, powders, and packaging inks, papers and covert markings. The device also detects products tampered re-labelling or re-gluing. The CD3 has been used to analyze almost 100 counterfeit products including drugs like Crestor, Lipitor, Oxycontin, Viagra, Tamiflu, Singulair, Plavix and Wellbutrin. If the two images received by the CD3 are not similar, it can be presumed that they are made of different materials or ingredients.

Free Sample Report@

However this device was made for screening large lots of drugs. The point of use devices such as PharmaCheck is much more useful as they check not only the right amount of ingredients, but also the dissolution rate and quantity of API in a sample. Conventional devices for preventing the flow of counterfeit drugs consist of spectrometry techniques such as Raman Spectroscopy through devices such as Thermo Scientific TruScan. Ceram a global company involved in material testing and analysis has applied technologies such as XPS and ToFSIMS for identifying counterfeit drugs. The U.S. Pharmacopeial Convention USP is currently providing support for research in developing a portable or hand-held device for pharmaceutical regulation. Other techniques such as chromatography involve destructive techniques for analyzing a sample. However, these devices and technologies are very bulky and cannot be transported to point of usage such as remote villages and even to developing countries. Current technological developments are paving the way for devices that analyze samples with non-destructive techniques. A paper based technique which visually acts as a litmus test for pharmaceuticals particularly Panadol is being developed by undergraduate researchers in Indiana. The priority is to decrease the cost per test in order to make it viable for extremely large lots that are imported and exported.

Anti-counterfeit technologies in pharmaceutical industries include visible markings for easy identification, invisible markings which can be identifiable only by pharmacies and distributers that contain special ink visible only under UV light or infrared, complex tracking and labelling such as DNA marking, RFID tagging etc. which can recognize simple encrypted serial numbers among others. The market for barcoding, RFID and Spectroscopy such as Raman, NIR and others together constitute maximum share for the counterfeit detection technologies. Excellent market growth is anticipated for these devices due to introduction of life saving drugs and vaccines, increasing health expenditure, awareness in identification of drugs and their biological actions, increasing generic drugs which tend to attract the sale of counterfeit drugs.

Click For Request TOC@

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Counterfeit Drug Detection Devices Market Revenue and Value Chain Till 2020 here

News-ID: 418436 • Views: 442

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases

More Releases for Device

Walking Assist Device
The Walking Assist Device Market 2018 Industry Research Report focused on global and regional market, major manufacturers, as well as the current state of the Walking Assist Devicese industry. First, " Walking Assist Devicese Industry 2018" report analyzed the basic scope of this industry like definition, specification, classification, application, industry policy, news analysis and Walking Assist Devicese industry chain structure. Walking Assist Device Market Top Players Honda Motor Co., Ltd., Permobil
Molded Interconnect Device Market
Molded Interconnect Device Market-Global Industry Analysis and Forecast (2018-2026) by Process, Product Type, End-user application and geography Molded Interconnect Device Market was valued US$ 300 Mn in 2017 and is expected to reach US$ 890.5 Mn by 2026 at a CAGR of 14.57% during forecast period. Molded Interconnect Device market is segmented by process, product, end-user application and region. Increasing demand in electrical and mechanical application, rising use of Molded Interconnect Device
Medical Device Technologies Market - The Evolution of Medical Device Technologie …
The global medical device technologies market is anticipated to be boosted by various well-known players in the market. Some of these players that are dealing with the manufacturing of in vitro diagnostic devices hold a significant share in the global market. Whereas, the small market players are emerging from several developing nations, looking to set their foot in the market. Such measures are foreseen to change the market scenario in
Timing Device Market
Asia Pacific traffic sensor market is expected to hold the majority share due to the adoption of technologically-advanced systems. Growing urban population and the increasing need for real-time information systems in the region will propel the traffic sensor market growth. Growing urban population in countries including India, China, Japan, and South Korea is increasing the strain on the traffic management solutions. This is encouraging the governments to invest increasingly in
Neurorehabilitation Devices - MIME Robotic Device
Bioness Inc., Bionik Laboratories Corp., Bioxtreme, Denecor, Ectron Ltd., Ekso Bionics, Helius Medical Technologies, Hocoma AG, MagVenture A/S, Medtronic, Neuro Style, Rehab-Robotics Company Limited, Rehabtronics Inc, St Jude Medical Inc., Tyromotion are some of the prominent players at the forefront of competition in the global Neurorehabilitation Devices Market and are profiled in MRFR Analysis. Global Neurorehabilitation Devices Market - Overview The neurorehabilitation devices market is growing with the rapid pace. According
Global Medical Device Connectivity Market
Global Medical Device Connectivity Market, By Type (Integration Software, Connectivity Hardware (Wired, Wireless (Wi-Fi, WMTS, Bluetooth), By Applications (Electronic Medical Record, Patient Monitoring, Others), By End-User (Hospitals, Community Healthcare, Clinics, Others), By Geography (North America, Europe, Asia Pacific, South America, Middle East & Africa) – Industry Trends and Forecast to 2024 The Global Medical Device Connectivity Market has accounted for USD 5.7 billion in 2016 and is expected to reach